More than 30,000 Americans have cystic fibrosis.
A genetic disease affecting the lungs.
Researchers are on the verge of creating a new test that could lead to better treatments.
So the University of Arizona researcher team hopes to replace this procedure, with a simple breath test.
Currently the only way to measure cholride levels in a patient's lungs is by inserting a tube into the airways, squirting a small amount of fluid and then sucking it out.
For more information on the clinical trial, email: clinicalresearch@pharmacy.arizona.edu or call (520)626-4127.
